SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy

Kathryn J. Swoboda, Charles B. Scott, Thomas O. Crawford et al. · 2010

Read SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy by Kathryn J. Swoboda, Charles B. Scott, Thomas O. Crawford et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012140.txt.

Description

Kathryn Swoboda, Charles Scott, Thomas Crawford, and colleagues reported a clinical trial in spinal muscular atrophy for PLOS ONE in 2010. This inherited disease weakens muscles by killing the nerve cells that drive them. Valproic acid, a drug long used for seizures, had shown promise for this disease in lab and animal work, and the trial added a supplement, L-carnitine, beside it.

Children and young patients joined in two groups: those who could sit but not walk, and those who could still walk. Half received the real treatment and half a dummy one, with neither side knowing which. Trials reported this carefully, part by part, give families and doctors trustworthy ground for judging a hoped-for therapy.

Catalog record

CREATORKathryn J. Swoboda, Charles B. Scott, Thomas O. Crawford et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE55 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012140

Browse the full library · About the Tower of Babel